Table 3.
Results from the symptom-limited graded exercise tests (SL-GXT).
| EECP (n=28) | SHAM (n=14) | ||||
|---|---|---|---|---|---|
| T1 (M ± SD) | T2 (M ± SD) | T1 (M ± SD) | T2 (M ± SD) | P, Between Group Comparison | |
| Peak VO2 (ml/kg/min) | 17.0±6.0 | 19.4±6.9† | 16.5±4.7 | 16.6±5.2 | 0.002 |
| Peak Exercise Duration (s) | 586.0±193.5 | 773.6±263.2† | 597.1±181.6 | 612.1±175.6 | < 0.001 |
| Peak Time to Angina (s) | 406.1±184.6 | 645.1±297.8‡ | 449.4±202.9 | 471.3±197.4 | 0.003 |
| Peak Angina Rating | 2.5±0.9 | 1.7±1.1† | 2.3±1.2 | 2.3±1.3 | 0.045 |
| Peak Heart Rate (bpm) | 112.4±13.8 | 117.4±18.9 | 115.6±20.1 | 119.1±19.1 | 0.550 |
| Rating of Perceived Exertion | 16.1±1.8 | 16.8±1.9 | 16.6±1.7 | 16.4±1.6 | 0.249 |
| Respiratory Exchange Ratio | 0.99±0.08 | 1.04±0.08 | 0.98±0.12 | 0.98±0.10 | 0.182 |
There were no significant differences between EECP and SHAM groups at baseline. Data are presented as mean ± SD. Significance values are also reported from within group repeated measures ANOVA and Tukey post hoc analysis;
†
p < 0.01,
‡
p < 0.001.